학술논문
Evaluation of natalizumab pharmacokinetics and pharmacodynamics with standard and extended interval dosing
Document Type
Article
Author
Source
In: Multiple Sclerosis and Related Disorders . (Multiple Sclerosis and Related Disorders, June 2019, 31:65-71)
Subject
Language
English
ISSN
22110356
22110348
22110348